Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, pursuant to Answer of 19 November 2018 to Question 190871 on Cancer, what the potential (a) advantages and (b) disadvantages are of implementing the national data guardian opt-out on the quality of the National Cancer Patient Experience Survey data.

As I stated in my previous response, we are giving careful consideration to the potential advantages and disadvantages of the application of the national data opt-out to the National Cancer Patient Experience Survey beyond 2018/19. A decision regarding the application of the national data opt-out to this survey and the Care Quality Commission National Patient Survey will be communicated shortly.